Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
My-Le NguyenVandana SachdevThomas R BurklowWen LiMegan StartzellSungyoung AuhRebecca J BrownPublished in: The Journal of clinical endocrinology and metabolism (2021)
Metreleptin attenuated cardiac hypertrophy and improved septal e' velocity in GLD, which may be mediated by reduced lipotoxicity and glucose toxicity. The applicability of these findings to leptin-sufficient populations remains to be determined.